G., Robbins, L
Rare but serious side effects, such as pancreatitis and thyroid tumors, have been reported with GLP-1 RAs
If you have a family member who developed medullary thyroid cancer before age 50, or if genetic testing confirmed MEN2A or MEN2B in your bloodline, semaglutide injections are not appropriate
CPT 96374, by contrast, covers intravenous (IV) push administration where the substance is delivered directly into a vein, typically by a syringe, and the administering provider must be present during the entire infusion
Some individuals find that tirzepatide reduces their desire for alcohol, a benefit reported in GLP-1 receptor agonist research
Our patients get access to a full article comparing tirzepatide and semaglutide in more detail including who tends to do better on which one, how to switch safely, and how to get the most from either.